Navigation path

Additional tools

  • Print version
  • Decrease text
  • Increase text
  • Choose high contrast version
  • Choose standard colour version

Profile of registrant

Novo Nordisk

Identification number in the register: 29570313329-11
Registration date: 13/03/10 10:09:51

The information on this organisation was last modified on 08/08/14 15:11:32
The date of the last annual update was 19/02/14 10:18:28

Registrant : Organisation or self-employed individual

Name/company name: Novo Nordisk
Legal status: Corporation
Website address:


Section: II - In-house lobbyists and trade/professional associations
and more precisely: Companies & groups

Person with legal responsibility

Surname, Name: Mr  Lars Rebien Sørensen
Position: CEO

Permanent person in charge of EU relations

Surname, Name: Mr  Morten Frank Pedersen
Position: Executive Director

Contact details:

Contact details of organisation's head office: 1 Novo Allé 
Bagsværd 2880
Telephone number: (+45) 44448888
Fax number: (+) 
Other contact information:

Goals / remit

Goals / remit of the organisation: Novo Nordisk is a global healthcare company with over 90 years of innovation and leadership in diabetes care. The company also has leading positions within haemophilia care, growth hormone therapy and hormone replacement therapy.

Headquartered in Denmark, Novo Nordisk employs approximately 35000 employees in 75 countries. It markets products and services that make a significant difference to patients, the medical profession and society in 190 countries.

Novo Nordisk is committed to developing its business towards environmental, social and financial sustainability (the triple bottom line). This commitment is demonstrated through its values and its environmental and social responsibility policies.

The Novo Nordisk Foundation is a non-profit institution, whose formal purpose is to provide a stable basis for its company's operations and to make contributions to scientific, humanitarian and social progress.

Novo A/S is an unlisted Danish public limited liability company, owned by the Novo Nordisk Foundation and established to manage the Foundation's funds and to invest actively in other companies.

All A and B shares in Novo Nordisk A/S, previously held by the Novo Nordisk Foundation, were transferred to Novo A/S on 31 December 1999. Novo Nordisk’s B shares are listed on the NASDAQ OMX Copenhagen (Novo-B). Its ADRs are listed on the New York Stock Exchange (NVO).
The organisation's fields of interests are:
  • global

Number of persons engaged in activities falling under the scope of the Transparency Register

Number of persons: 3
Complementary information:

Persons accredited for access to European Parliament premises

First name Surname Start Date End Date
Troels Anders RYE-ANDERSEN 08/08/14 06/08/15
Ane Sofie Böhm Nielsen 23/09/14 19/09/15


Main EU initiatives covered the year before by activities falling under the scope of the Transparency Register:

- improve conditions for prevention, treatment and care in Europe to address unmet needs

- support the voice of people living with or at risk of
developing diabetes

- increase Europe´s competitiveness as a location for Research and Development investment

Fields of interest for e-mail alerts on consultations and roadmaps;

Fields declared by the organisation:
  • Competition
  • Enterprise
  • Environment
  • Internal Market
  • Public Health
  • Research and Technology


Information on (i) organisation's membership of any associations/federations/confederations or (ii) relationships to other bodies in formal or informal networks.

Novo Nordisk is member of:

EFPIA - European Federation of Pharmaceutical Industries and Associations

EBE - European Biopharmaceutical Enterprises

EuropaBio - European Association for Bioindustries

Financial data

Financial year: 01/2014 - 08/2014
Estimated costs to the organisation directly related to representing interests to EU institutions in that year: 50000  € - 100000  €
Amount and source of funding received from the EU institutions in financial year n-1 of registration
Procurement: 0 €
Grants: 0 €
Other (financial) information provided by the organisation:

Code of conduct

By its registration the organisation has signed the Transparency Register Code of Conduct.